Puma Biotechnology | PBYI - 利息收入





利息收入 更改 日
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Daiichi Sankyo JPY 9.96B 230M 2024-03
Exelixis USD 14.21M 1.92M 2026-06
Gilead Sciences USD 95M 0 2026-03
Glaxosmithkline GBP 22M 4M 2026-03
Incyte USD 38.12M 4.43M 2026-06
MacroGenics USD 1.55M 26K 2026-03
Moderna USD 72M 2M 2026-03
Pfizer USD -0.04 115M 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sarepta Therapeutics USD 7M 1.74M 2026-03
Takeda JPY 24.61B 213.76B 2026-06
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06